Literature DB >> 26614383

Tubuloreticular Inclusions in Renal Allografts Associate with Viral Infections and Donor-Specific Antibodies.

Michelle Willicombe1, Jill Moss2, Linda Moran2, Paul Brookes3, Eva Santos-Nunez3, Adam G McLean4, Thomas Cairns4, David Taube4, Terence H Cook5, Candice Roufosse5.   

Abstract

The presence of tubuloreticular inclusions (TRIs) in native glomerular endothelial cells associates with viral infections and lupus nephritis. However, the associations of TRIs in renal transplant biopsy specimens are not known. We analyzed data from 316 patients who had a transplant biopsy with electron microscopy examination; 41 of 316 (13.0%) patients had TRIs. Patients with TRIs had significantly lower allograft survival rates (50.9%) than patients without TRIs (74.3%; P=0.03). Transplant glomerulopathy-free survival was also inferior in the TRI-positive group (57.5%) compared with the TRI-negative group (87.3%; P=0.002). Serologically, hepatitis C associated with the presence of TRIs (P=0.04) along with donor-specific antibodies (P=0.01). Furthermore, patients who were TRI positive were more likely than patients who were TRI negative to have had a previous rejection episode (P=0.02). On multivariate analysis, TRIs associated with prior rejection, viral infections, and class 1 HLA donor-specific antibodies. These results show that the presence of TRIs in renal allograft biopsy specimens associates with poor allograft outcomes and serologic evidence of viral infections and alloimmunity. The association with alloimmunity is a novel finding that warrants additional investigation.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  immunology and pathology; kidney transplantation; rejection; transplant outcomes; transplant pathology

Mesh:

Substances:

Year:  2015        PMID: 26614383      PMCID: PMC4926975          DOI: 10.1681/ASN.2015050478

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta.

Authors:  S P Hammar; J Y Luu; D E Bockus; F L Remington; J W Luu; S Friedman; M A Bean
Journal:  Ultrastruct Pathol       Date:  1992 Jan-Apr       Impact factor: 1.094

Review 2.  Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.

Authors:  Robert B Colvin
Journal:  J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 10.121

Review 3.  Interferons and autoimmune disorders.

Authors:  Olivier Meyer
Journal:  Joint Bone Spine       Date:  2009-09-20       Impact factor: 4.929

4.  Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

Authors:  R K Sharma; S B Bansal; A Gupta; S Gulati; A Kumar; N Prasad
Journal:  Clin Transplant       Date:  2006 Nov-Dec       Impact factor: 2.863

5.  Viral RNA and DNA trigger common antiviral responses in mesangial cells.

Authors:  Ramanjaneyulu Allam; Julia Lichtnekert; Anton G Moll; Anela Taubitz; Volker Vielhauer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

Review 6.  Immune regulation of human herpesviruses and its implications for human transplantation.

Authors:  C Smith; R Khanna
Journal:  Am J Transplant       Date:  2013-02       Impact factor: 8.086

7.  The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy.

Authors:  An-Hang Yang; Bing-Shi Lin; Ko-Lin Kuo; Chung-Chen Chang; Yee-Yung Ng; Wu-Chang Yang
Journal:  Nephrol Dial Transplant       Date:  2009-06-17       Impact factor: 5.992

Review 8.  Antiviral immune responses: triggers of or triggered by autoimmunity?

Authors:  Christian Münz; Jan D Lünemann; Meghann Teague Getts; Stephen D Miller
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

9.  Late-acute renal allograft rejection and symptomless cytomegalovirus infection.

Authors:  P Reinke; E Fietze; S Ode-Hakim; S Prösch; J Lippert; R Ewert; H D Volk
Journal:  Lancet       Date:  1994 Dec 24-31       Impact factor: 79.321

10.  Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.

Authors:  M Haas; B Sis; L C Racusen; K Solez; D Glotz; R B Colvin; M C R Castro; D S R David; E David-Neto; S M Bagnasco; L C Cendales; L D Cornell; A J Demetris; C B Drachenberg; C F Farver; A B Farris; I W Gibson; E Kraus; H Liapis; A Loupy; V Nickeleit; P Randhawa; E R Rodriguez; D Rush; R N Smith; C D Tan; W D Wallace; M Mengel
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

View more
  4 in total

1.  Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation.

Authors:  Jinghui Yang; Jianjun Chen; James S Young; Qiang Wang; Dengping Yin; Roger Sciammas; Anita S Chong
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

2.  One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial.

Authors:  Meghan Elizabeth Sise; David Seth Goldberg; Douglas Earl Schaubel; Robert J Fontana; Jens J Kort; Rita R Alloway; Christine M Durand; Emily A Blumberg; E Steve Woodle; Kenneth E Sherman; Robert S Brown; John J Friedewald; Niraj M Desai; Samuel T Sultan; Josh Levitsky; Meghan D Lee; Ian A Strohbehn; J Richard Landis; Melissa Fernando; Jenna L Gustafson; Raymond T Chung; Peter Philip Reese
Journal:  Kidney Int Rep       Date:  2021-12-01

3.  Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and Hypertension.

Authors:  Teresa K Chen; Michelle M Estrella; Lawrence J Appel; Josef Coresh; Shengyuan Luo; Jochen Reiser; Wassim Obeid; Chirag R Parikh; Morgan E Grams
Journal:  Am J Kidney Dis       Date:  2021-01-01       Impact factor: 11.072

Review 4.  COVID-19 update: Covid-19-associated coagulopathy.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.